Table 1 Baseline characteristics
From: A dietary intervention for chronic diabetic neuropathy pain: a randomized controlled pilot study
Variable | All particiants (N=34) | Intervention group (N=17) | Supplement group (N=17) | P-value* |
|---|---|---|---|---|
Women, N | 19 | 11 (65%) | 8 (47%) | 0.56 |
College degree, N | 18 | 10 (59%) | 8 (47%) | 0.88 |
Black race, N | 16 | 5 (29%) | 11 (65%) | 0.09 |
Hispanic, N | 5 | 1 (6%) | 4 (24%) | 0.34 |
Age, years | 57 (6)a | 57 (6) | 58 (6) | 0.48 |
Weight, kg | 104 (23) | 102 (23) | 106 (24) | 0.70 |
BMI, kg m−2 | 36 (6) | 36 (6) | 36 (7) | 0.90 |
Diabetes duration, years | 14 (10) | 15 (11) | 12 (10) | 0.60 |
Total cholesterol, mg dl−1 | 172 (44) | 171 (48) | 173 (41) | 0.89 |
Triglycerides, mg dl−1 | 152 (77) | 151 (66) | 153 (89) | 0.95 |
HbA1c, % | 7.9 (1.6) | 8.0 (1.7) | 7.8 (1.6) | 0.78 |
HbA1c, mmol ml−1 | 63 (18) | 64 (19) | 62 (18) | 0.78 |
Fasting glucose, mg dl−1 | 159 (66) | 161 (74) | 157 (60) | 0.89 |
MNSI-PA | 4.1 (2.3) | 4.8 (2.4) | 3.4 (2.2) | 0.09 |
NIS-LL | 8.9 (6.9) | 11.3 (8.0) | 6.6 (4.6) | 0.05 |
Visual analog scale, cm | 5.5 (2.6) | 5.3 (2.7) | 5.8 (2.4) | 0.57 |
MPQ-T | 22 (10) | 23 (11) | 21 (10) | 0.65 |
QOL-T | 29 (15) | 28 (14) | 30 (16) | 0.74 |
NTSS-6 | 12 (5) | 11 (5) | 12 (5) | 0.35 |
On metformin | 24 | 12 (71%) | 12 (71%) | 0.99 |
On insulin | 15 | 6 (35%) | 9 (53%) | 0.30 |
On other agents | 17 | 10 (59%) | 7 (41%) | 0.31 |
